Skip to main content
v2026.11,986 entries · CC-BY 4.0
LAC HealthSponsored

Shop medical supplies

  • FDA registered
  • ISO 13485
  • BBB Accredited A+

Shop at LAC Health

21 CFR 820.198 Complaint Files: What Each Paragraph Required and Where It Sits Now

Paragraph-by-paragraph reading of 21 CFR 820.198 complaint files, and where the duty sits under the QMSR in 820.35(a) and 820.10(b)(3).

Written and maintained by CASRAI Editorial Board

Published · Last updated

On this page

General regulatory information from the Code of Federal Regulations and FDA; not legal or medical advice.

Short answer

21 CFR 820.198 was the section of the former Quality System Regulation that required device manufacturers to keep complaint files and to run a formally designated unit that receives, reviews and evaluates complaints. The Quality Management System Regulation (QMSR) took effect on February 2, 2026, and the current Part 820 no longer contains a section 820.198. Its complaint-record duties now sit mainly in 21 CFR 820.35(a), read together with ISO 13485 Clause 8.2.2.

Definition and scope: what 820.198 said

The legacy text (eCFR version dated 2025-01-01) had seven paragraphs. Paragraph (a) required each manufacturer to maintain complaint files and procedures for receiving, reviewing and evaluating complaints by a formally designated unit. Those procedures had to ensure that complaints are processed in a uniform and timely manner, that oral complaints are documented on receipt, and that each complaint is evaluated to decide whether it is an event reportable to FDA under Part 803 (Medical Device Reporting).

It is the numbering that older SOPs, audit checklists and supplier questionnaires still cite, which is why searches for "21 CFR 820.198" and "medical device complaint handling 820.198" persist after the rule changed.

How the complaint file works, paragraph by paragraph

Legacy paragraph What it required What a file reviewer looks for
(a) Complaint files; written procedures; a formally designated unit; uniform and timely processing; oral complaints documented on receipt; evaluation for Part 803 reportability A procedure that names the unit, and a reportability decision on every complaint
(b) Review and evaluate all complaints to decide whether an investigation is needed; if none is made, keep a record of the reason and the name of the individual who decided For each uninvestigated complaint, a stated reason and a named decision-maker
(c) Investigate any complaint involving possible failure of a device, labeling or packaging to meet a specification, unless a similar complaint was already investigated and another investigation is unnecessary An investigation, or a pointer to the earlier investigation of a similar complaint
(d) Part 803-reportable complaints are promptly reviewed, evaluated and investigated by designated individual(s), kept in a separate portion of the files or clearly identified, and the record states whether the device failed specifications, whether it was used for treatment or diagnosis, and the device’s relationship to the incident Reportable complaints that are easy to isolate, with all three determinations recorded
(e) Investigation record held by the designated unit: device name, date received, UDI or UPC and other identification and control numbers, complainant name, address and phone, nature and details, dates and results of the investigation, corrective action, reply to the complainant Every listed data element present in each investigated complaint
(f) If the designated unit is at a different site from manufacturing, investigated complaints and records must be reasonably accessible to the manufacturing establishment Evidence the manufacturing site can retrieve the records
(g) If the unit is outside the United States, records must be reasonably accessible in the US, at a US location where the manufacturer’s records are regularly kept or at the initial distributor A named US access location

Source for the table: 21 CFR 820.198, eCFR version dated 2025-01-01.

Status after the QMSR: where the duty went

FDA states that the QMSR became effective on February 2, 2026 and amends Part 820 by incorporating ISO 13485:2016 by reference. In the current eCFR structure (version dated 2026-03-01) Part 820 contains Subpart A (General Provisions) and Subpart B (Supplemental Provisions), and Subparts C through O are marked [Reserved]. There is therefore no section 820.198 to cite for current requirements.

The complaint-record content now appears in two places in the current text:

  • 21 CFR 820.35(a), Records of complaints. In addition to ISO 13485 Clause 8.2.2 (Complaint Handling), the manufacturer must keep records of the review, evaluation and investigation of any complaint involving possible failure of a device, labeling or packaging to meet a specification. Where an investigation was already done for a similar complaint, the manufacturer must keep records documenting the justification for not investigating again.
  • 21 CFR 820.10(b)(3). For ISO 13485 Clause 8.2.3 (Reporting to regulatory authorities), the manufacturer must notify FDA of complaints that meet the reporting criteria of Part 803.

Legacy (e) compared with 820.35(a)

Comparing the two texts side by side shows what changed in the data elements. The legacy 820.198(e) list had eight items. The 820.35(a) list has seven: device name, date received, UDI or UPC and any other device identification, complainant name, address and phone number, nature and details of the complaint, any correction or corrective action taken, and any reply to the complainant. The legacy items "dates and results of the investigation" and "control number(s) used" do not appear in the 820.35(a) list. Section 820.35(a) says it applies in addition to Clause 8.2.2, and a reviewer should check that clause as well. The legacy separate-portion rule for reportable complaints in paragraph (d) has no counterpart sentence in 820.35(a).

Where it matters for labs, clinics and supply decisions

A complaint about a device or consumable, such as a labeling error or damaged packaging, is passed to the manufacturer’s complaint unit, and the duty to keep the complaint file sits with the manufacturer. Old supplier-qualification forms and SOPs that cite 820.198 are still readable as a statement of the expected content: designated unit, reportability decision, reason recorded when no investigation is made, and the data elements above. When updating such a document, cite 21 CFR 820.35 and 820.10(b)(3) and ISO 13485 Clause 8.2.2 for current requirements, and keep 820.198 only as a labelled legacy reference. For the reportability decision itself, see 21 CFR Part 806 on corrections and removals and the FDA definition of serious injury.

FDA also states that exemption from the CGMP requirements does not exempt manufacturers of finished devices from keeping complaint files or from the general records requirements of 21 CFR 820.35.

Common misunderstandings

  • "820.198 is still in force." The current Part 820 text has no such section; Subparts C-O are reserved (eCFR, 2026-03-01).
  • "The complaint file duty ended with the old rule." It did not. Section 820.35(a) keeps complaint records, and FDA says exempt manufacturers still keep complaint files.
  • "Every complaint needs a full investigation." Under the legacy text, paragraph (b) allowed no investigation if the reason and the responsible individual were recorded; under 820.35(a), a justification record is required where a similar complaint was already investigated.
  • "A complaint file and a CAPA file are the same record." They are separate requirements; see CAPA and FDA for the corrective-action side.

FAQ

What is 21 CFR 820.198?

It was the complaint files section of the former Quality System Regulation, requiring a formally designated unit and records of how each complaint was reviewed, evaluated and, where needed, investigated.

What replaced 21 CFR 820.198?

Under the QMSR effective February 2, 2026, 21 CFR 820.35(a) adds complaint-record requirements on top of ISO 13485 Clause 8.2.2, and 820.10(b)(3) covers notifying FDA of Part 803-reportable complaints.

How does medical device complaint handling under 820.198 compare with the current rule?

The designated-unit, uniform-and-timely, and oral-complaint language of legacy paragraph (a) does not appear in 820.35(a), which instead builds on ISO 13485 Clause 8.2.2. The record data elements are listed in 820.35(a). For the full process view, see complaint handling for medical devices and the Part 820 subpart map.

Sources

Date checked for all sources below: 2026-11-01.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about 21 CFR 820.198 Complaint Files: What Each Paragraph Required and Where It Sits Now

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →